Taiwan FDA registration 5dbc64ac0515f42d4e29382c4e1991fc
"Pewei" postoperative wound care system
TW: “佩威”術後傷口照護系統
Taiwan·Risk Class 2·KCI USA, Inc.;; KCI Manufacturing·Registered Jan 19, 2017 – Jan 19, 2027ActiveRegistration details
- Analysis ID
- 5dbc64ac0515f42d4e29382c4e1991fc
- Customs Code
- DHA05602881001
Company information
- Manufacturer
- KCI USA, Inc.;; KCI Manufacturing
- Manufacturer Country
- Ireland;;United States
- Authorized Representative
- 3M Healthcare Taiwan Co., Ltd.
Product details
- Intended Use
- To treat surgical incisions that still leak to the outside after sutures or staples, wound negative pressure therapy techniques are used to provide a closed environment and remove exudate.
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.4780 動力式抽吸幫浦
- Import Information
- Input;; Contract manufacturing
Dates and status
- Registration Date
- Jan 19, 2017
- Expiry Date
- Jan 19, 2027
About this record
Access comprehensive regulatory information for "Pewei" postoperative wound care system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5dbc64ac0515f42d4e29382c4e1991fc and manufactured by KCI USA, Inc.;; KCI Manufacturing. The authorized representative in Taiwan is 3M Healthcare Taiwan Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices